GLP-1 Agonists Show Possible Benefits for Rare Blood Cancer

(MedPage Today) — HOUSTON — Patients with polycythemia vera (PV) and a history of treatment with GLP-1 agonists had significantly lower rates of multiple adverse outcomes associated with the disease, a large propensity-matched study showed…